ZA201604468B - Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis - Google Patents
Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosisInfo
- Publication number
- ZA201604468B ZA201604468B ZA2016/04468A ZA201604468A ZA201604468B ZA 201604468 B ZA201604468 B ZA 201604468B ZA 2016/04468 A ZA2016/04468 A ZA 2016/04468A ZA 201604468 A ZA201604468 A ZA 201604468A ZA 201604468 B ZA201604468 B ZA 201604468B
- Authority
- ZA
- South Africa
- Prior art keywords
- exosomes
- genomic dna
- proteins
- theranosis
- rna
- Prior art date
Links
- 210000001808 exosome Anatomy 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000004797 therapeutic response Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361911863P | 2013-12-04 | 2013-12-04 | |
| PCT/US2014/068630 WO2015085096A1 (en) | 2013-12-04 | 2014-12-04 | Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201604468B true ZA201604468B (en) | 2024-01-31 |
Family
ID=53274132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/04468A ZA201604468B (en) | 2013-12-04 | 2016-06-30 | Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9921223B2 (enExample) |
| EP (1) | EP3076949B1 (enExample) |
| JP (3) | JP2017501694A (enExample) |
| AU (3) | AU2014360344B2 (enExample) |
| CA (1) | CA2936100A1 (enExample) |
| DK (1) | DK3076949T3 (enExample) |
| HR (1) | HRP20192131T1 (enExample) |
| HU (1) | HUE046489T2 (enExample) |
| LT (1) | LT3076949T (enExample) |
| NZ (1) | NZ721720A (enExample) |
| SI (1) | SI3076949T1 (enExample) |
| WO (1) | WO2015085096A1 (enExample) |
| ZA (1) | ZA201604468B (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
| WO2006116362A2 (en) | 2005-04-25 | 2006-11-02 | The Trustees Of Boston University | Structured substrates for optical surface profiling |
| US11286463B2 (en) | 2012-03-08 | 2022-03-29 | Advanced ReGen Medical Technologies, LLC | Reprogramming of aged adult stem cells |
| US9828603B2 (en) | 2012-08-13 | 2017-11-28 | Cedars Sinai Medical Center | Exosomes and micro-ribonucleic acids for tissue regeneration |
| WO2014028862A1 (en) | 2012-08-17 | 2014-02-20 | Cornell University | Use of dna in circulating exosomes as a diagnostic marker for metastasic disease |
| EP2971162B1 (en) | 2013-03-15 | 2019-05-08 | Board Of Regents, The University Of Texas System | Mirna biogenesis in exosomes for diagnosis and therapy |
| DK3076949T3 (da) * | 2013-12-04 | 2019-11-25 | Univ Texas | Fremgangsmåde til isolering af kræftcelle-afledte eksosomer |
| WO2015095794A1 (en) | 2013-12-20 | 2015-06-25 | Advanced ReGen Medical Technologies, LLC | Compositions for cellular restoration and methods of making and using same |
| US10772911B2 (en) | 2013-12-20 | 2020-09-15 | Advanced ReGen Medical Technologies, LLC | Cell free compositions for cellular restoration and methods of making and using same |
| EP3125907A4 (en) * | 2014-04-01 | 2017-11-29 | Cornell University | Use of double-stranded dna in exosomes: a novel biomarker in cancer detection |
| US11357799B2 (en) | 2014-10-03 | 2022-06-14 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| WO2016057702A2 (en) | 2014-10-07 | 2016-04-14 | Cornell University | Methods for prognosing and preventing metastatic liver disease |
| US11971402B2 (en) | 2015-04-24 | 2024-04-30 | Cornell University | Methods and reagents for determination and treatment of organotropic metastasis |
| US11339441B2 (en) * | 2015-05-12 | 2022-05-24 | The Research Foundation For The State University Of New York | Profiling chemically modified DNA/RNA units for disease and cancer diagnosis |
| US10345310B2 (en) | 2015-06-09 | 2019-07-09 | The Board Of Regents Of The University Of Texas System | Diagnostic test for early stage cancer |
| CA2988585A1 (en) | 2015-06-10 | 2016-12-15 | Raghu Kalluri | Use of exosomes for the treatment of disease |
| CA2999283A1 (en) | 2015-09-22 | 2017-03-30 | Trustees Of Boston University | Multiplexed phenotyping of nanovesicles |
| GB201518466D0 (en) * | 2015-10-19 | 2015-12-02 | Cizzle Biotechnology Ltd | Use |
| EP3402543B1 (en) | 2016-01-11 | 2021-09-08 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction |
| JP7033082B2 (ja) * | 2016-02-05 | 2022-03-09 | ナノビュー バイオサイエンシズ インコーポレイテッド | 表面マーカーを有するエキソソームの検出 |
| SG11201807401RA (en) * | 2016-03-15 | 2018-09-27 | Codiak Biosciences Inc | Therapeutic membrane vesicles |
| WO2017190000A1 (en) | 2016-04-29 | 2017-11-02 | Advanced ReGen Medical Technologies, LLC | Microrna compositions and methods of making and using same |
| US11351200B2 (en) | 2016-06-03 | 2022-06-07 | Cedars-Sinai Medical Center | CDC-derived exosomes for treatment of ventricular tachyarrythmias |
| EP3472623A4 (en) * | 2016-06-21 | 2020-01-15 | Nant Holdings IP, LLC | TREATMENT OF CANCER GUIDED BY EXOSOME |
| CN106124282B (zh) * | 2016-07-26 | 2019-07-16 | 广州海力特生物科技有限公司 | 一种叠层离心过滤分离提取外泌体的方法 |
| US20180067121A1 (en) * | 2016-09-06 | 2018-03-08 | Nanoco Technologies Ltd. | Exosome-conjugated quantum dot nanoparticles and methods of detecting exosomes and cancer using same |
| EP3515459A4 (en) | 2016-09-20 | 2020-08-05 | Cedars-Sinai Medical Center | CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS |
| IL269483B2 (en) * | 2017-03-21 | 2024-04-01 | Exoprother Medical Ltd | Native cell derived vesicles containing tumor suppressor proteins for therapy |
| GB2560897A (en) * | 2017-03-23 | 2018-10-03 | Lotvall Jan | Tissue-derived extracellular vesicles and their use as diagnostics |
| US11759482B2 (en) | 2017-04-19 | 2023-09-19 | Cedars-Sinai Medical Center | Methods and compositions for treating skeletal muscular dystrophy |
| CN107338306A (zh) * | 2017-07-23 | 2017-11-10 | 嘉兴允英医学检验有限公司 | 一种用于GPC1mRNA表达检测的试剂盒 |
| JP2020529477A (ja) * | 2017-08-04 | 2020-10-08 | シーダーズ—シナイ メディカル センター | がんの治療及び防止のためのカルディオスフィア由来細胞及びその細胞外小胞 |
| GB2574785A (en) | 2017-09-15 | 2019-12-25 | Jan Loetvall | Method and system for identifying membrane proteins on extracellular vesicles |
| CN111566484A (zh) * | 2017-11-09 | 2020-08-21 | 宾夕法尼亚大学董事会 | 细胞外囊泡蛋白及其在癌症诊断、预测对疗法的反应和治疗中的用途 |
| US20210285952A1 (en) | 2017-12-01 | 2021-09-16 | Cornell University | Nanoparticles and distinct exosome subsets for detection and treatment of cancer |
| US11660355B2 (en) | 2017-12-20 | 2023-05-30 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
| AU2018394238A1 (en) * | 2017-12-28 | 2020-06-18 | Lonza Sales Ag | Exosomes for immuno-oncology and anti-inflammatory therapy |
| EP3740576A4 (en) | 2018-01-18 | 2021-10-20 | Advanced Regen Medical Technologies, LLC | THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| US12241888B2 (en) | 2018-03-14 | 2025-03-04 | Children's Medical Center Corporation | Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof |
| CN112533643A (zh) * | 2018-03-28 | 2021-03-19 | 得克萨斯州大学系统董事会 | 外排体用于靶向递送治疗剂的用途 |
| JP7474702B2 (ja) * | 2018-03-28 | 2024-04-25 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法 |
| WO2019199803A1 (en) * | 2018-04-09 | 2019-10-17 | Board Of Regents, The University Of Texas System | Therapeutic targeting of oncogenes using exosomes |
| CN112105736A (zh) * | 2018-05-04 | 2020-12-18 | 西格马-奥尔德里奇有限责任公司 | 生产具有降低宿主细胞蛋白水平的重组蛋白 |
| WO2019232321A1 (en) | 2018-06-01 | 2019-12-05 | NanoView Biosciences, Inc. | Compositions, systems, and methods for enhanced label-free and fluorescence - based detection of nanoparticles |
| US11119798B2 (en) | 2018-11-15 | 2021-09-14 | Sternum Ltd. | Applying control flow integrity verification in intermediate code files |
| US11766484B2 (en) | 2019-01-03 | 2023-09-26 | International Business Machines Corporation | Exosome vessels for delivery of molecular cargo |
| WO2020146390A1 (en) | 2019-01-09 | 2020-07-16 | Exocure Biosciences, Inc. | Bacteria-derived vesicles and uses thereof |
| WO2020160402A1 (en) * | 2019-02-01 | 2020-08-06 | NanoView Biosciences, Inc. | Systems and methods for vesicle cargo labeling and detection |
| WO2020163724A1 (en) * | 2019-02-08 | 2020-08-13 | Board Of Regents, The University Of Texas System | Isolation and detection of exosome-associated microbiome for diagnostic and therapeutic purposes |
| WO2020219699A1 (en) * | 2019-04-23 | 2020-10-29 | Children's Medical Center Corporation | Use of rab7 gtpase (rab7) inhibitors in enhancing permeability of the blood brain barrier (bbb) |
| JP7462452B2 (ja) * | 2020-03-27 | 2024-04-05 | 株式会社日立製作所 | 培養細胞の分化レベルを評価するための評価装置および評価方法、並びに自動細胞培養システム |
| CN112698033A (zh) * | 2020-12-09 | 2021-04-23 | 复旦大学附属中山医院 | 一种血源性外泌体her2的检测方法及其应用 |
| US20230340606A1 (en) * | 2021-09-09 | 2023-10-26 | The Regents Of The University Of California | Extracellular repetitive rna biomarkers of mutant kras cancers |
| US20250011876A1 (en) * | 2021-11-02 | 2025-01-09 | The Regents Of The University Of California | Extracellular rna signatures of mutant kras(g12c) cancers |
| WO2023210644A1 (ja) * | 2022-04-26 | 2023-11-02 | 国立大学法人東京大学 | がん細胞由来細胞外小胞群の単離濃縮方法、分析方法、薬剤選択方法、キット、及び抗がん剤 |
| US20250290919A1 (en) * | 2022-05-06 | 2025-09-18 | The Trustees Of The University Of Pennsylvania | Ultrasensitive single extracellular vesicle detection using high throughput droplet digital enzyme-linked immunosorbent assay |
| WO2024047441A1 (en) * | 2022-09-01 | 2024-03-07 | Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud - Centro De Investigação Da Fundação Champalimaud | Method for monitoring tumor burden in subjects during therapeutic intervention |
| WO2024073671A1 (en) * | 2022-09-30 | 2024-04-04 | Foundation Medicine, Inc. | Systems and methods for processing clinico-genomic data |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824311A (en) | 1987-11-30 | 1998-10-20 | Trustees Of The University Of Pennsylvania | Treatment of tumors with monoclonal antibodies against oncogene antigens |
| US4870287A (en) | 1988-03-03 | 1989-09-26 | Loma Linda University Medical Center | Multi-station proton beam therapy system |
| US5846945A (en) | 1993-02-16 | 1998-12-08 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| GB9506466D0 (en) | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
| US5760395A (en) | 1996-04-18 | 1998-06-02 | Universities Research Assoc., Inc. | Method and apparatus for laser-controlled proton beam radiology |
| US5739169A (en) | 1996-05-31 | 1998-04-14 | Procept, Incorporated | Aromatic compounds for inhibiting immune response |
| US20030064949A1 (en) | 1998-02-17 | 2003-04-03 | Loretta Nielsen | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| FR2766205B1 (fr) * | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
| KR100519384B1 (ko) * | 2002-08-13 | 2005-10-06 | (주)누백스 | 유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도 |
| EP2604704B1 (en) * | 2008-02-01 | 2018-10-03 | The General Hospital Corporation | Use of microvesicles in diagnosis and prognosis of brain tumor |
| US20120196285A1 (en) * | 2011-01-31 | 2012-08-02 | Esoterix Genetic Laboratories, Llc | Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules |
| US9777042B2 (en) | 2011-12-15 | 2017-10-03 | Morehouse School Of Medicine | Method of purifying HIV/SIV Nef from exosomal fusion proteins |
| US9309559B2 (en) * | 2013-04-15 | 2016-04-12 | Albert Einstein College Of Medicine, Inc. | Simultaneous extraction of DNA and RNA from FFPE tissues |
| DK3076949T3 (da) * | 2013-12-04 | 2019-11-25 | Univ Texas | Fremgangsmåde til isolering af kræftcelle-afledte eksosomer |
-
2014
- 2014-12-04 DK DK14867768T patent/DK3076949T3/da active
- 2014-12-04 EP EP14867768.5A patent/EP3076949B1/en active Active
- 2014-12-04 SI SI201431412T patent/SI3076949T1/sl unknown
- 2014-12-04 JP JP2016536918A patent/JP2017501694A/ja not_active Ceased
- 2014-12-04 WO PCT/US2014/068630 patent/WO2015085096A1/en not_active Ceased
- 2014-12-04 US US15/101,857 patent/US9921223B2/en active Active
- 2014-12-04 CA CA2936100A patent/CA2936100A1/en active Pending
- 2014-12-04 NZ NZ721720A patent/NZ721720A/en not_active IP Right Cessation
- 2014-12-04 HU HUE14867768A patent/HUE046489T2/hu unknown
- 2014-12-04 HR HRP20192131TT patent/HRP20192131T1/hr unknown
- 2014-12-04 LT LT14867768T patent/LT3076949T/lt unknown
- 2014-12-04 AU AU2014360344A patent/AU2014360344B2/en not_active Ceased
-
2016
- 2016-06-30 ZA ZA2016/04468A patent/ZA201604468B/en unknown
-
2017
- 2017-11-01 US US15/801,269 patent/US10598665B2/en active Active
-
2019
- 2019-01-30 AU AU2019200573A patent/AU2019200573A1/en not_active Abandoned
- 2019-02-25 AU AU2019201290A patent/AU2019201290A1/en not_active Withdrawn
- 2019-08-13 JP JP2019148579A patent/JP2019198327A/ja not_active Withdrawn
-
2020
- 2020-03-04 US US16/809,300 patent/US20200200755A1/en not_active Abandoned
-
2021
- 2021-07-02 JP JP2021110830A patent/JP7138372B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180045728A1 (en) | 2018-02-15 |
| AU2019200573A1 (en) | 2019-02-21 |
| US10598665B2 (en) | 2020-03-24 |
| WO2015085096A1 (en) | 2015-06-11 |
| JP2017501694A (ja) | 2017-01-19 |
| EP3076949A1 (en) | 2016-10-12 |
| SI3076949T1 (sl) | 2020-01-31 |
| EP3076949A4 (en) | 2017-11-22 |
| HRP20192131T1 (hr) | 2020-02-21 |
| NZ721720A (en) | 2022-04-29 |
| US20200200755A1 (en) | 2020-06-25 |
| US9921223B2 (en) | 2018-03-20 |
| EP3076949B1 (en) | 2019-09-04 |
| US20170059572A1 (en) | 2017-03-02 |
| AU2019201290A1 (en) | 2019-03-14 |
| CA2936100A1 (en) | 2015-06-11 |
| LT3076949T (lt) | 2019-12-10 |
| JP7138372B2 (ja) | 2022-09-16 |
| HUE046489T2 (hu) | 2020-03-30 |
| JP2019198327A (ja) | 2019-11-21 |
| JP2021177760A (ja) | 2021-11-18 |
| DK3076949T3 (da) | 2019-11-25 |
| AU2014360344B2 (en) | 2018-11-29 |
| AU2014360344A1 (en) | 2016-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201604468B (en) | Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis | |
| Nagel et al. | Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research | |
| Briehl | Oxygen in human health from life to death–An approach to teaching redox biology and signaling to graduate and medical students | |
| MX2014016014A (es) | Metodos para determinar eficacia de farmacos usando proteinas asociadas a cereblon. | |
| EA201500334A1 (ru) | Fgfr3 гибридный ген и лекарственный препарат, нацеленный на него | |
| EP4339288A3 (en) | Oligonucleotide probes and uses thereof | |
| WO2012122564A3 (en) | Diagnostic and sample preparation devices and methods | |
| SG195191A1 (en) | Methods and compositions of predicting activity of retinoid x receptor modulator | |
| PH12016500425B1 (en) | Il-18 binding protein (il-18bp) in inflammatory diseases | |
| BR112016017986A2 (pt) | anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo | |
| EP3686200A3 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| EA201791167A1 (ru) | Способы и композиции для мечения радиоактивным изотопомf биологических препаратов | |
| EP2569453A4 (en) | Nucleic Acid ISOLATION METHOD | |
| WO2014026768A8 (en) | Colorectal cancer markers | |
| MX362514B (es) | Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato. | |
| MX2018012143A (es) | Métodos de diagnóstico para la toma de decisiones terapéuticas específicas del paciente en el cuidado del cáncer. | |
| WO2016040891A3 (en) | In vitro compositions comprising human sample and amyloid targeting agent | |
| WO2015014903A3 (en) | Diagnostic tools for alzheimer's disease | |
| WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
| WO2014124339A3 (en) | Use of translational profiling to identify target molecules for therapeutic treatment | |
| WO2015081283A3 (en) | Long non-coding rna as a diagnostic and therapeutic agent | |
| MX2019008005A (es) | Metodos y composiciones para diagnosticar preeclampsia. | |
| WO2015069883A3 (en) | Oxidized fraction of extracellular dna as a biomarker of stress and methods for using the same | |
| CA2967867C (en) | Methods for detection and treatment of colorectal cancer | |
| BR112016028838A2 (pt) | anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer |